alanine and chlorambucil

alanine has been researched along with chlorambucil in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Donelli, MG; Garattini, S; Rosso, R	1
Awasthi, S; Awasthi, YC; Pal, A; Pandya, U; Singh, SV; Singhal, SS; Srivastava, SK; Zimniak, P	1
Barrientos, JC	1

Reviews

1 review(s) available for alanine and chlorambucil

Article	Year
Sequencing of chronic lymphocytic leukemia therapies. Hematology. American Society of Hematology. Education Program, 2016, Dec-02, Volume: 2016, Issue:1 Topics: Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Proliferation; Chlorambucil; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease-Free Survival; DNA Mutational Analysis; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Rituximab; Smith-Magenis Syndrome; Tumor Suppressor Protein p53	2016

Article

Year

Sequencing of chronic lymphocytic leukemia therapies.

Hematology. American Society of Hematology. Education Program, 2016, Dec-02, Volume: 2016, Issue:1

Topics: Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cell Proliferation; Chlorambucil; Chromosome Deletion; Chromosomes, Human, Pair 17; Cyclophosphamide; Disease-Free Survival; DNA Mutational Analysis; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Rituximab; Smith-Magenis Syndrome; Tumor Suppressor Protein p53

2016

Other Studies

2 other study(ies) available for alanine and chlorambucil

Article	Year
On the neurotoxic effects induced by alkylating agents. The Journal of pharmacy and pharmacology, 1966, Volume: 18, Issue:11 Topics: Alanine; Animals; Anti-Bacterial Agents; Antimetabolites; Azaserine; Behavior, Animal; Central Nervous System; Chlorambucil; Cyclophosphamide; Cysteine; Drug Antagonism; Glycine; Male; Mannitol; Mechlorethamine; Melphalan; Nitrogen Mustard Compounds; Phenobarbital; Phenytoin; Rats; Seizures; Spasm; Thiourea; Triethylenemelamine; Tryptophan	1966
Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil. Biochemical and biophysical research communications, 2000, Nov-11, Volume: 278, Issue:1 Topics: Alanine; Alkylating Agents; Alleles; Antineoplastic Agents, Alkylating; Catalysis; Chlorambucil; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glutathione Transferase; Humans; Isoleucine; Kinetics; Polymorphism, Genetic; Protein Isoforms; Thiotepa; Valine	2000

Article

Year

On the neurotoxic effects induced by alkylating agents.

The Journal of pharmacy and pharmacology, 1966, Volume: 18, Issue:11

Topics: Alanine; Animals; Anti-Bacterial Agents; Antimetabolites; Azaserine; Behavior, Animal; Central Nervous System; Chlorambucil; Cyclophosphamide; Cysteine; Drug Antagonism; Glycine; Male; Mannitol; Mechlorethamine; Melphalan; Nitrogen Mustard Compounds; Phenobarbital; Phenytoin; Rats; Seizures; Spasm; Thiourea; Triethylenemelamine; Tryptophan

1966

Activity of allelic variants of Pi class human glutathione S-transferase toward chlorambucil.

Biochemical and biophysical research communications, 2000, Nov-11, Volume: 278, Issue:1

Topics: Alanine; Alkylating Agents; Alleles; Antineoplastic Agents, Alkylating; Catalysis; Chlorambucil; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glutathione Transferase; Humans; Isoleucine; Kinetics; Polymorphism, Genetic; Protein Isoforms; Thiotepa; Valine

2000